Results 191 to 200 of about 28,757,677 (326)

Complement factor H-related hybrid protein deregulates complement in dense deposit disease.

Journal of Clinical Investigation, 2014
Qiang Chen, M. Wiesener, H. Eberhardt, A. Hartmann, B. Uzonyi, M. Kirschfink, K. Amann, M. Buettner, T. Goodship, C. Hugo, C. Skerka, P. Zipfel   +11 more
semanticscholar   +1 more source

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

Molecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon, Moa Stenudd, Margherita Zamboni, Kanar Alkass, Carl‐Johan Eriksson, Lars Pedersen, Alrik Schörling, Anna Thoss, Anders Bergh, Pernilla Wikström, Hans‐Olov Adami, Henrik Toft Sørensen, Henrik Druid, Jonas Frisén   +13 more
wiley   +1 more source

Factor H: a novel modulator in sickle cell disease

Haematologica, 2019
Wassim El Nemer, Bérengère Koehl
doaj   +1 more source

Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab. [PDF]

Haematologica
Ardissino G, Angelillo P, Mancuso MC, Griffini S, Grovetti E, Porcaro L, Ria T, Marktel S, Peyvandi F, Luminari S, Ferreri AJM, Merli M, Cugno M.   +12 more
europepmc   +1 more source

Timing as a prominent factor of the Jendrassik manoeuvre on the H reflex.

, 1975
Tomoko Kawamura, Shiro Watanabe
openalex   +1 more source

Mucha H., E. Keller, H. Weber, F. Lingens and W. Trösch, Sirohydrochlorin, a precursor of factor F₄₃₀ biosynthesis in Methanobacterium thermoautotrophicum (1985) FEBS Letters 190, 169‐171 [PDF]

, 1986

openalex   +1 more source

Complement factor H: a biomarker for progression of cutaneous squamous cell carcinoma.

Journal of Investigative Dermatology, 2014
P. Riihilä, L. Nissinen, R. Ala‐aho, M. Kallajoki, R. Grénman, S. Meri, S. Peltonen, J. Peltonen, V. Kähäri   +8 more
semanticscholar   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

Molecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková, Marie Ehrlichová, Alžběta Spálenková, Ivona Krus, Simona Šůsová, Viktor Hlaváč, Vlasta Němcová, Renata Koževnikovová, Markéta Trnková, David Vrána, Jiří Gatěk, Kateřina Kopečková, Marcela Mrhalová, Soňa Měšťáková, Pavel Souček   +14 more
wiley   +1 more source

Complement Factor H Is an ICOS Ligand Modulating Tregs in the Glioma Microenvironment. [PDF]

Cancer Immunol Res
Smolag KI, Olszowka J, Rosberg R, Johansson E, Marinko E, Leandersson K, O'Connell DJ, Governa V, Tuysuz EC, Belting M, Pietras A, Martin M, Blom AM.   +12 more
europepmc   +1 more source

A New Simple Method of Calculating Thermodynamic Properties of Products of Combustion in Jet Engines and Gas Turbines : 4th Report, The Enthalpy and Entropy of Products of Combustion with Dissociations of CO, H<SUB>2</SUB>, and OH, and Their Dependence on the Excess Air Factor

, 1971
Keikichi TANAKA, Noriyasu ISHIDA, Kiyoshi IDEHARA   +2 more
openalex   +2 more sources